Clinical Trial Update: Venetoclax Plus Inotuzumab for B-ALL [Phase 1]

View source ↗

Summary

This is an update on a Phase 1 trial of venetoclax plus inotuzumab ozogamicin for B-cell acute lymphoblastic leukemia and B-cell lymphoma; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Lymphoma

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)
• Venclexta (venetoclax)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING